gamer456148

Moderna's Phase 2, $90 Target Inevitable

Short
NASDAQ:MRNA   Moderna, Inc.
First off, please don't take anything I say seriously or as financial advice. As always, this is on opinion based basis. Moderna's Covid19 vaccine for mRNA-1273 is reaching Phase 2 clinical trails by the FDA which is further ahead than most of its small competitors and bio-pharmaceutical corporations. As always, you see the big giant crushing the small one. This news is expected to have a surge in buy signals and once it passes the $70 threshold quite soon, it will lead to a $90 short being the next actual target. That's right it can go that high, and who would be surprised?

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.